Zenas BioPharma, Inc.

US$28.26As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ZBIOHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR 27.59%
Div yield —
ROE (265.11%)
Biotechnology
Beta (5Y) (0.86)
PE TTM —
TSR TTM (9.57%)
Mkt cap US$1.917B
ROIC (53.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$31
9.42%
(46.14%)
Hold 10|5|2|1|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.54
0.59
0.58
0.58
24.13%
26.65%
18.27%
16.52%
Revenue$M
129.6
126.6
125.0
124.0
(4.01%)
(3.71%)
(6.75%)
(6.76%)
Peers (US$1.917B)
Cap (US$)
PE
1.944B
10.95x
Capital
TTM
5Y
10Y
Leveragex
0.077
(0.096)
(0.099)
EBIT/Intx
2.434
0.544
0.527
Own earn%
35.03
(118.61)
(116.24)
Sh yield%
36.21
35.41
38.31
Owners
Insiders/Inst%
11.43
29.82
Short interest%
3.33
SBC / revenue%
5.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
12–18
$1 testx
0.0
Incr. ROIC%
11